MWV study | Mean et al. [39] | Gupta et al. [41] | Singh S. et al. [42] | Shilpa Garg. et al. [43] |
Use | Multiple warts | Anogenital warts | Extensive extra genital cutaneous warts | single or multiple warts |
Sensitization with 0.1 ml | Done and then after two weeks subsequent injections were given | Done sensitization, subsequent | Done, and 2 weeks after doses given | Not done |
Dosing interval | 1 week | 1 week | 2 weeks | 4 weeks |
Dose | 0.1 mL | 0.1 mL | <0.1 mL | 0.1 mL |
Route | Intralesional to 3 - 5 lesions at a time | Intralesional injections in <3 warts | Intralesional to 2-4 warts | Intralesional in a single wart or the largest in case of multiple |
Maximum doses | 10 | 10 | 10 | 10 |
Success rate | 83% clearance | 88.9% clearance | 54.5% | 93.3% |
Recurrence | In (3 out of 37) | No recurrence after 5 months | No recurrences during 3 - 9 months | In 14.28% of patients at new site |